aragenpic
Outsourced R&D and manufacturing offers substantial cost efficiency, driven by specialized expertise, economies of scale, and access to skilled talent, finds Ind-Ra.

Be Sure To Read

photo_1_dr
Co-CEO Minzhang Chen says the increasing size and complexity of drug molecules require greater knowledge and a sophisticated approach.
trumpeosign
The Assistant Secretary for Preparedness and Response must come up with a list of approximately 26 drugs, secure a six-month supply, and prioritize domestic sourcing.
eli_lilly_concord
The industry’s robotics market showed the strongest sector growth in the second quarter of 2025, according to new data from the Association for Advancing Automation.
fdawhiteoakbuilding
While the agency’s PreCheck regulatory framework is a good first step, it remains to be seen whether the program boosts U.S. drug manufacturing, says former FDA official.
lifecore_sign
The contract manufacturer has 11 late-stage projects with commercial approval potential within the next few years, including a developer of GLP-1 therapeutics for obesity.
janjhqnj
The Garden State, called the “medicine chest” to the world, continues to show robust activity with life sciences firms accounting for nearly 30% of all Q2 leasing activity.

Exclusives

Pharma events calendar

Keep track of in-person industry events.


Articles

The latest content from industry thought leaders.


Editors' (re)View

Weekly takes on things going on in the pharma world.

featured_image
Discover how Aquafine® UV systems offer a compact solution ideal for pharmaceutical water treatment. Delivering ultra-low residuals, minimal downtime, and compliance with stringent...
beamex_software
Discover how automated calibration improves compliance, reduces human error, and increases efficiency in pharmaceutical manufacturing. This Beamex white paper explores the benefits...
shutterstock_479766829
Unlock the full potential of your GMP assets. Discover how life sciences organizations can optimize reliability, compliance, and performance with a data-driven approach to Asset...
prgreenquadrant2025verdantixthumbnaillinkedin
Successful AI-enabled operations depend on a solid industrial data strategy. Get there faster with these vendors.
pressreleasebenchmarkreportingfullhd
Confident you're using the right language model for your industrial application? See how they stack up in this unique report.
pressreleasecognitereleasefullhd
Three of Cognite's chemical, refining, and energy customers take center stage in this product tour video that showcases why and how they are transforming their operations.

With a focus on CGT manufacturing, BioForge will be operational by 2027.
Building on its manufacturing legacy, Pittsburgh is now headed in a new direction — from steel to science

shutterstock_2079390133
The future of non-clinical research may depend on integrating VCGs for a more humane and efficient approach.
A look at consequential drug approvals and rejections from this year
Michael Annino/Shutterstock AI
With key players entering the ring and many clinical trials underway, the molecular glue garden is bound to bloom soon
A first-of-its-kind study of isotopic values of paired reactants and products offers a prospective new method of process understanding

shutterstock_2467268685
Adhering to a tried-and-true set of best practices during the PPQ stage can prevent a drug approval from stalling out on the final lap.

Michael Annino | Shutterstock-AI
pm2409_hero854x480_2
Pharmacologic approaches to treating aging are edging closer to maturity
Michael Annino/Shutterstock AI
pm2409_hero854x480_2coverstory
New treatments offer the promise of tackling age-related disease multimorbidity
Michael Annino/Shutterstock AI
pm2409_hero854x480_coverstory
Novel therapeutic approaches to aging are creating a healthspan market with staying power

Slideshows

A robust contamination control strategy isn't merely a guideline, it's a necessity
Microsoft Teams Image (7)
Quick answers to all your pharma manufacturing questions
Shutterstock 749369605
13 pharma scaries….and solutions that offer reprieve